Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Westlake Chemical Partners (WLKP) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Westlake Chemical Partners (WLKP) over the last 12 years, with Q3 2025 value amounting to $1.4 million.

  • Westlake Chemical Partners' Net Cash Flow rose 12343.29% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$22.3 million, marking a year-over-year decrease of 29342.87%. This contributed to the annual value of -$303000.0 for FY2024, which is 9508.36% up from last year.
  • Per Westlake Chemical Partners' latest filing, its Net Cash Flow stood at $1.4 million for Q3 2025, which was up 12343.29% from -$13.0 million recorded in Q2 2025.
  • In the past 5 years, Westlake Chemical Partners' Net Cash Flow registered a high of $45.3 million during Q4 2022, and its lowest value of -$45.2 million during Q2 2023.
  • For the 5-year period, Westlake Chemical Partners' Net Cash Flow averaged around $1.1 million, with its median value being $135000.0 (2021).
  • As far as peak fluctuations go, Westlake Chemical Partners' Net Cash Flow surged by 294993.71% in 2022, and later crashed by 512011.56% in 2023.
  • Westlake Chemical Partners' Net Cash Flow (Quarter) stood at -$1.6 million in 2021, then soared by 2949.94% to $45.3 million in 2022, then tumbled by 116.0% to -$7.2 million in 2023, then skyrocketed by 73.9% to -$1.9 million in 2024, then skyrocketed by 171.72% to $1.4 million in 2025.
  • Its Net Cash Flow stands at $1.4 million for Q3 2025, versus -$13.0 million for Q2 2025 and -$8.7 million for Q1 2025.